Polyethylene glycol hydrazone, polyethylene glycol oxime linkage forming reagents and protein derivatives thereof
AU1425499A
Multilayered controlled release pharmaceutical dosage form
US5994563A
Arylmethylphosphonic acid derivatives useful in treating bone wasting diseases
US6136559A
DNA encoding as human histamine receptor of the H3 subtype
US5925769A
Acetylenic 1,5-diarylpyrazoles as antiinflammatory agents
WO9909993A1
Combinations of endometrial sparing progestins and endometrial atrophizing progestins with estrogens, in oral contraception
US6251956B1
Combination progestin oral contraceptive regimen
US6039208A
Variable day start tablet dispenser
WO9824814A2
N-terminally modified polypeptide enzyme inhibitors, and related therapeutic methods and pharmaceutical compositions
US5843958A
Arylpyrazoles as leukotriene inhibitors
CN1236435A
A dissolution test method for solid steroidal pharmaceutical formulations
WO9817636A1
Phenylalaninol derivatives for the treatment of central nervous system disorders
US5908754A
Method for in vitro determination of in vivo erythropoeitin bioactivity
ZA9708934B
5-Heteroatom-containing alkyl substituted-3-oxo-pyrido(1,2-a) benzimidazole-4-carboxamide derivatives useful in treating central nervous system disorders
WO9815553A1
5-HETEROATOM-CONTAINING ALKYL SUBSTITUTED-3-OXO-PYRIDO(1,2-a) BENZIMIDAZOLE-4-CARBOXAMIDE DERIVATIVES USEFUL IN TREATING CENTRAL NERVOUS SYSTEM DISORDERS